• Home
• convert 44c to f
• Current scenario on non-nucleoside reverse transcriptase inhibitors (2018-present) - ScienceDirect

Current scenario on non-nucleoside reverse transcriptase inhibitors (2018-present) - ScienceDirect

5 (194) · $ 15.99 · In stock

A review on synthesis of antiviral drugs, in silico studies and

Current scenario on non-nucleoside reverse transcriptase

Novel natural non-nucleoside inhibitors of HIV-1 reverse

Repurposing nucleoside reverse transcriptase inhibitors (NRTIs) to

Reverse transcriptase - ScienceDirect

Nucleotide and nucleoside-based drugs: past, present, and future

Chemical diversity and activity profiles of HIV-1 reverse

Design, synthesis, and antiviral evaluation of novel piperidine

Current scenario on non-nucleoside reverse transcriptase

Repurposing nucleoside reverse transcriptase inhibitors (NRTIs) to

Human anti-N1 monoclonal antibodies elicited by pandemic H1N1

Picomolar inhibitor of reverse transcriptase featuring